Lemaitre Vascular (LMAT) Restructuring Costs (2011 - 2023)
Lemaitre Vascular's (LMAT) quarterly Restructuring Costs came in at $15000.0 in Q4 2023, up 314.29% year-over-year from $3620.7 in Q4 2022, and down 91.67% quarter-over-quarter from $180000.0 in Q2 2023.
Powered by 
Analysis
Lemaitre Vascular (LMAT) Restructuring Costs (2011 - 2023) Analysis & Trends
Lemaitre Vascular (LMAT) has reported Restructuring Costs for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2023.
- On a quarterly basis, Restructuring Costs rose 314.29% year-over-year to $15000.0 in Q4 2023; TTM through Sep 2024 was $15000.0, a 96.86% decrease from a year earlier, with the FY2023 full-year figure at $500000.0, down 83.87% from the prior year.
- Restructuring Costs was $15000.0 for Q4 2023 at Lemaitre Vascular, down from $180000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $3.1 million in Q2 2022 and troughed at -$7000.0 in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | Lemaitre Vascular | 1.80 Bn | 1.43 Bn | 50.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 15,000.00 |
| Jun 30, 2023 | 180,000.00 |
| Mar 31, 2023 | 305,000.00 |
| Dec 31, 2022 | -7,000.00 |
| Jun 30, 2022 | 3.11 Mn |
| Dec 31, 2014 | 26,000.00 |
| Sep 30, 2014 | 8,000.00 |
| Jun 30, 2014 | 89,000.00 |
| Mar 31, 2014 | 403,000.00 |
| Dec 31, 2011 | -1.75 Mn |
| Sep 30, 2011 | 394,000.00 |
| Jun 30, 2011 | 650,000.00 |
| Mar 31, 2011 | 1.01 Mn |